A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

US regulators approved Leqembi in 2023 and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved the ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Could a pill offer the brain-boosting benefits of exercise? A recent study in mice, led by scientists at the (USC), suggests ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

New research from Auburn University shows a new drug might be a preventive for Alzheimer’s Disease. The study’s main ...

The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval ...

Alzheimer’s disease is the most common brain condition in older adults worldwide and a leading cause of dementia. Despite ...

Snyder also noted that “there are barriers and gaps in investment that help move exciting new approaches like this into ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Officials said over 71,000 Oklahomans are currently living with Alzheimer's disease. Nationally, that number is approaching 7 ...